Location: Greenwich, CT
CIK: 0001856083 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 12, 2022
Total Value: $1.521B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | GLOBAL BLOOD THERAPEUTICS IN | 3,646,690 | $117M | 7.7% | $30.70 | — | COM | 37890U108 |
| NVCR | NOVOCURE LTD | 1,341,300 | $93.22M | 6.1% | $85.04 | -11.4% | ORD SHS | G6674U108 |
| TVTX | TRAVERE THERAPEUTICS INC | 3,580,700 | $86.76M | 5.7% | $27.48 | -8.5% | COM | 89422G107 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 500,000 | $78M | 5.1% | $131.87 | +16.7% | SHS USD | G50871105 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 499,900 | $72.91M | 4.8% | $152.35 | -6.9% | Call | 02043Q107 |
| KURA | KURA ONCOLOGY INC | 3,697,969 | $67.78M | 4.5% | $15.65 | -8.1% | COM | 50127T109 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 905,000 | $64.78M | 4.3% | $81.70 | -10.0% | COM | 558868105 |
| — | CHINOOK THERAPEUTICS INC | 3,430,110 | $59.99M | 3.9% | $16.47 | — | COM | 16961L106 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 654,365 | $54.23M | 3.6% | $79.62 | 0.0% | COM | 09061G101 |
| FATE | FATE THERAPEUTICS INC | 2,018,005 | $50.01M | 3.3% | $42.48 | -35.0% | COM | 31189P102 |
| BCYC | BICYCLE THERAPEUTICS PLC | 2,900,000 | $48.66M | 3.2% | $40.57 | — | SPONSORED ADS | 088786108 |
| BEAM | BEAM THERAPEUTICS INC | 1,250,000 | $48.39M | 3.2% | $66.76 | -40.5% | COM | 07373V105 |
| — | IVERIC BIO INC | 4,500,000 | $43.29M | 2.8% | $16.73 | — | COM | 46583P102 |
| — | AGENUS INC | 22,241,417 | $43.15M | 2.8% | $2.27 | — | COM NEW | 00847G705 |
| ESPR | ESPERION THERAPEUTICS INC NE | 6,000,000 | $38.16M | 2.5% | $7.78 | -27.2% | COM | 29664W105 |
| — | REPARE THERAPEUTICS INC | 2,707,662 | $37.88M | 2.5% | $19.55 | — | COM | 760273102 |
| NUVB | NUVATION BIO INC | 11,471,281 | $37.17M | 2.4% | $4.49 | -2.8% | COM CL A | 67080N101 |
| IMVT | IMMUNOVANT INC | 9,455,000 | $36.88M | 2.4% | $6.80 | -36.5% | COM | 45258J102 |
| NKTX | NKARTA INC | 2,814,844 | $34.68M | 2.3% | $14.20 | -7.6% | COM | 65487U108 |
| NRIX | NURIX THERAPEUTICS INC | 2,436,164 | $30.87M | 2.0% | $11.33 | 0.0% | COM | 67080M103 |
| — | FORMA THERAPEUTICS HLDGS INC | 4,050,000 | $27.91M | 1.8% | $7.88 | — | SHS | 34633R104 |
| — | TRICIDA INC | 2,732,117 | $26.45M | 1.7% | $9.41 | — | COM | 89610F101 |
| ACAD | ACADIA PHARMACEUTICALS INC | 1,733,130 | $24.42M | 1.6% | $18.68 | 0.0% | COM | 004225108 |
| DYN | DYNE THERAPEUTICS INC | 3,500,000 | $24.05M | 1.6% | $12.14 | -43.3% | COM | 26818M108 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 3,140,000 | $21.92M | 1.4% | $19.72 | -50.7% | COM | 35104E100 |
| KROS | KEROS THERAPEUTICS INC | 739,528 | $20.43M | 1.3% | $49.95 | -12.2% | COM | 492327101 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,053,000 | $19.64M | 1.3% | $24.65 | -19.0% | COM | 22663K107 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,824,000 | $17.95M | 1.2% | $15.47 | -28.7% | COM | 483497103 |
| — | DICE THERAPEUTICS INC | 1,042,900 | $16.19M | 1.1% | $25.31 | — | COM | 23345J104 |
| — | INOZYME PHARMA INC | 3,250,000 | $15.5M | 1.0% | $4.77 | — | COM | 45790W108 |
| SDGR | SCHRODINGER INC | 562,000 | $14.84M | 1.0% | $26.87 | 0.0% | COM | 80810D103 |
| ABOS | ACUMEN PHARMACEUTICALS INC | 3,100,000 | $14.57M | 1.0% | $8.63 | -56.5% | COM | 00509G209 |
| ANAB | ANAPTYSBIO INC | 672,569 | $13.65M | 0.9% | $28.89 | -23.3% | COM | 032724106 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,170,290 | $13.54M | 0.9% | $18.63 | -27.9% | COM | 92790C104 |
| — | ADICET BIO INC | 892,028 | $13.02M | 0.9% | $14.60 | — | COM | 007002108 |
| — | JOUNCE THERAPEUTICS INC | 4,259,653 | $12.91M | 0.8% | $8.25 | — | COM | 481116101 |
| SLN | SILENCE THERAPEUTICS PLC | 951,580 | $11.28M | 0.7% | $23.89 | — | ADS | 82686Q101 |
| RLMD | RELMADA THERAPEUTICS INC | 500,000 | $9.495M | 0.6% | $21.58 | +1.1% | COM | 75955J402 |
| — | HOOKIPA PHARMA INC | 5,035,998 | $8.209M | 0.5% | $2.28 | — | COM | 43906K100 |
| IPSC | CENTURY THERAPEUTICS INC | 924,641 | $7.767M | 0.5% | $14.74 | -33.5% | COM | 15673T100 |
| — | MAGENTA THERAPEUTICS INC | 5,359,000 | $6.431M | 0.4% | $4.29 | — | COM | 55910K108 |
| — | ASSEMBLY BIOSCIENCES INC | 3,000,000 | $6.3M | 0.4% | $2.33 | — | COM | 045396108 |
| — | SAGE THERAPEUTICS INC | 171,800 | $5.549M | 0.4% | $40.09 | — | COM | 78667J108 |
| — | PASSAGE BIO INC | 2,320,000 | $5.475M | 0.4% | $6.20 | — | COM | 702712100 |
| GHRS | GH RESEARCH PLC | 499,400 | $4.984M | 0.3% | $21.97 | -40.8% | ORDINARY SHARES | G3855L106 |
| FULC | FULCRUM THERAPEUTICS INC | 1,000,000 | $4.9M | 0.3% | $16.30 | -40.0% | COM | 359616109 |
| — | GRITSTONE BIO INC | 1,720,000 | $4.162M | 0.3% | $9.31 | — | COM | 39868T105 |
| TNYA | TENAYA THERAPEUTICS INC | 483,836 | $2.724M | 0.2% | $21.79 | -62.9% | COM | 87990A106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 260,500 | $2.061M | 0.1% | — | — | Put | 74366E102 |
| ATYR | ATYR PHARMA INC | 290,844 | $823K | 0.1% | $8.35 | -56.7% | COM NEW | 002120202 |
| — | VIGIL NEUROSCIENCE INC | 308,393 | $796K | 0.1% | $7.03 | — | COM | 92673K108 |